To examine the direct effect of EMMPRIN on breast cancer stem-like cells, SUM102 and BT474 cells were treated with the indicated concentration of human recombinant EMMPRIN (hrEMMPRIN) and stem-like cell properties were analyzed. The gene discussed is BSG; the disease is breast cancer.